» Authors » Ahmed Elkaryoni

Ahmed Elkaryoni

Explore the profile of Ahmed Elkaryoni including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 62
Citations 87
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Elkaryoni A, Hyder O, Saad M, Darki A, Elgendy I, Mamdani S, et al.
Circ Cardiovasc Qual Outcomes . 2024 Nov; 17(11):e011038. PMID: 39492716
No abstract available.
2.
Imran H, Has P, Kassis N, Shippey E, Elkaryoni A, Gordon P, et al.
JACC Cardiovasc Interv . 2024 Oct; 17(20):2367-2376. PMID: 39477639
Background: Transfemoral (TF) access is the preferred approach for transcatheter aortic valve replacement (TAVR). Limited data exist regarding the outcomes of intravascular lithotripsy (IVL)-assisted TF TAVR in patients with peripheral...
3.
Elkaryoni A, Saad M
J Am Heart Assoc . 2024 Aug; 13(17):e036240. PMID: 39190597
No abstract available.
4.
Marginean A, Arora P, Walsh K, Bruno E, Sawalski C, Gupta R, et al.
Clin Appl Thromb Hemost . 2024 Aug; 30:10760296241278353. PMID: 39183532
Objectives: To construct a new scoring system utilizing biomarkers, vitals, and imaging data to predict 30-day mortality in acute pulmonary embolism (PE). Background: Acute PE, a well-known manifestation of venous...
5.
Shatla I, Iskandarani M, Khan M, Elkaryoni A, Elbadawi A, Goel S, et al.
J Soc Cardiovasc Angiogr Interv . 2024 Aug; 3(5):101360. PMID: 39132462
Background: Pulmonary embolism is one of the leading causes of morbidity and mortality in the United States. Catheter-directed therapies have emerged as a promising treatment for managing intermediate- and high-risk...
6.
Sedhom R, Beshai R, Elkaryoni A, Megaly M, Elbadawi A, Athar A, et al.
Am J Med Open . 2024 Jul; 10:100053. PMID: 39035241
Background: Data on outcomes of patients with high-risk acute pulmonary embolism (PE) transferred from other hospitals are scarce. Methods: We queried the Nationwide Readmissions Database for admissions who were ≥18...
7.
Elkaryoni A, Hyder O, Saad M
N Engl J Med . 2024 Jun; 390(24):2327. PMID: 38924741
No abstract available.
8.
Shatla I, Mehta N, Kennedy K, Elkaryoni A, Wimmer A
Europace . 2024 Jun; 26(7). PMID: 38902965
No abstract available.
9.
Saad M, Elkaryoni A, Alkhouli M
JACC Cardiovasc Interv . 2024 May; 17(11):1322-1324. PMID: 38795090
No abstract available.
10.
Elkaryoni A, Huded C, Saad M, Altibi A, Chhatriwalla A, Abbott J, et al.
JACC Cardiovasc Imaging . 2024 May; 17(8):926-936. PMID: 38703172
Patients with normal-flow low-gradient (NFLG) severe aortic stenosis present both diagnostic and management challenges, with debate about the whether this represents true severe stenosis and the need for valve replacement....